• SENSEX 80,242.24
    -46.14 (--0.06%)
  • BANKNIFTY 55,087.15
    -304.10 (--0.55%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Mazagon Dock
    3,149.70 3,149.70(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Cochin Shipyard
    1,575.50 1,169.00(%)
  • Tata Motors
    641.10 542.55(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Torrent Pharma.
    3,300.00 2,513.05(%)
  • Sonata Software
    446.50 762.00(%)
  • Data Pattern
    2,450.00 1,350.50(%)
  • IndusInd Bank
    843.10 1,550.00(%)
  • Samvardh. Mothe.
    131.75 107.30(%)
  • Bharat Electron
    312.50 221.00(%)
  • Trent
    5,130.00 4,197.50(%)
  • Varun Beverages
    507.45 419.40(%)
  • ICICI Bank
    1,415.10 1,051.50(%)
  • Vedanta
    423.20 527.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Vivo Bio Tech Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3920.0
  • ISIN : INE380K01017
38.94 0 (-0.66%)
  • As on 30 Apr 2025 (EOD)
  • Today’s Low

    38.55
  • Today’s High

    40.88
  • Open

    38.55
  • Perv Close

    39.20
  • 52W Low

    31.20
  • 52W High

    56.90

Key Indicators

  • P/E(TTM)

    9.86

  • Mar.Cap (₹Cr.)

    69.80

  • Div & Yield %

    0.00

  • Book Value(₹)

    38.60

  • Debt-Equity Ratio

    -0.66

  • AGM Date

    30-Apr-2025

  • EPS

    3.95

  • P/E Ratio

    9.86

Financials Ratios

  • Debt-Equity Ratio

    1.27

  • Mar.Cap (₹Cr.)

    69.80

  • RONW (%)

    4.76

  • ROCE (%)

    9.88

Score Board

  • Equity (₹ in Cr.)

    17.92

  • BV (₹)

    38.60

  • Sales( ₹ in Cr.)

    44.88

  • NP (in Cr.)

    2.52

  • NP Var(%)

    -4.0

  • Div%

    0.0

  • CPS (₹)

    6.60

  • EPS (₹)

    1.40

  • Traded Value (₹ in Lakhs)

    70.27

  • 52 Week High

    56.90

  • 52 Week Low

    31.20

  • Price BSE

    39.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    70.27

  • P/C Ratio

    5.90

  • P/E Ratio

    27.70

  • Price Vs.BV

    1.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 44.88 51.62 51.39 51.78 55.35 55.83
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 44.88 51.62 51.39 51.78 55.35 55.83
Other Income 0.04 0.04 0.09 0.08 0.05 0.01
Stock Adjustments 0.80 -1.84 -3.47 2.70 2.34 0.65
Total Income 45.72 49.82 48.01 54.56 57.74 56.49
EXPENDITURE :            
Raw Materials 4.65 4.93 7.97 9.91 10.90 12.41
Power and Fuel Cost 3.93 4.27 3.56 5.78 4.69 2.93
Employee Cost 10.13 13.15 9.42 8.57 10.00 9.58
Other Manufacturing Expenses 1.68 2.56 3.03 1.42 4.50 5.79
Selling and Administration Expenses 4.01 3.05 7.76 11.02 6.93 9.53
Miscellaneous Expenses 0.02 0.00 0.10 -0.02 8.21 6.73
Employee Benefit Expenses 10.13 13.15 9.42 8.57 10.00 9.58
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 24.43 27.96 31.83 36.67 45.22 46.97
Operating Profit 21.30 21.86 16.18 17.88 12.53 9.52
Interest 7.95 7.99 4.27 3.67 3.10 2.64
Gross Profit 13.35 13.87 11.91 14.21 9.43 6.88
Depreciation 9.29 9.27 7.44 5.59 5.17 5.06
Profit Before Tax 4.06 4.60 4.47 8.62 4.26 1.82
Current Tax 1.68 1.03 0.76 1.36 1.12 0.38
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.14 0.94 1.51 1.58 -1.31 -0.80
Reported Net Profit 2.52 2.63 2.20 5.68 4.44 2.25
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 2.52 2.63 2.20 5.68 4.44 2.25
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 18.98 16.35 14.15 8.46 4.02 1.77
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 21.51 18.98 16.35 14.15 8.46 4.02
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.69 1.77 1.54 4.24 3.45 1.82
Earnings Per Share(Adj)-Unit Curr 1.69 1.77 1.54 4.24 3.45 1.82
Book Value 36.50 34.81 32.57 30.64 25.63 21.85
Book Value(Adj)-Unit Curr 36.50 34.81 32.57 30.64 25.63 21.85

Shareholding Pattern

  • Promoter Group

    43.36%

  • Public Share Holding

    56.64%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 5,812,000 32.42 5,812,000 6
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,959,500 10.93 459,500 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,771,500 43.36 6,271,500 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,978,597 11.04 1,674,441 45
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 349,262 1.95 349,262 84
Foreign Non Institution Other 1,861,909 10.39 561,909 2
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,877,123 10.47 1,802,123 36
Individuals holding nominal share capital up to Rs. 1 lakh 4,086,325 22.80 3,855,348 21,756
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 100 0.00 100 1
Sub Total 10,153,316 56.64 8,243,183 21,924
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 17,924,816 100.00 14,514,683 21,935

Company Background

Vivo Bio Tech LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Vivo Bio Tech Ltd
  • BSE Code : 3920.0
  • ISIN : INE380K01017
  • Incorporation Year

    1987

  • Registered Office

    Survey #349/A Pregnapur Vlge
    , Gajel,
    Telangana-502311

  • Telephone

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    A V Kiran

  • Auditor

    P Murali & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Aarthi Consultants Pvt Ltd
    1-2-285,
    Domalguda,J B Apartments
    Mumbai - Hyderabad - 500 029

Vivo Bio Tech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Vivo Bio Tech 38.94 44.92 44.88 9.86 10.06
Abbott India 29,876.95 6,097.18 5,848.91 47.58 44.71
Astrazeneca Phar 8,665.50 1,330.33 1,295.53 223.40 33.26
P & G Health Ltd 5,072.65 1,166.89 1,151.26 35.59 39.76
Glaxosmi. Pharma 2,959.45 3,530.73 3,407.25 58.85 44.44
Cipla 1,549.65 17,645.00 16,574.34 26.57 20.10
Amrutanjan Healt 692.80 437.58 421.23 40.61 20.84
Guj. Themis Bio. 272.65 174.19 169.82 56.45 44.82
Fermenta Biotec. 260.70 315.24 307.09 24.71 4.10
Bliss GVS Pharma 119.00 638.96 605.46 27.23 11.19
Ambalal Sarabhai 36.46 11.70 3.81 15.58 1.92